The visit comprised two days of visits to Universities and Hospitals, two days at the inaugural medtechNorth conference and a one day exploratory workshop to identify possibilities for future Quebec/UK MedTech research collaborations.
David Cudby, Cambridge Wireless SIG Champion and Founder of Networks for Independent Living, explained the purpose of the trip and some of the impressive advances in technology that the party viewed – “We saw research into wireless technology and processes to support independent living in aging, dementia and chronic diseases, a wearable detector for breast cancer and improving effectiveness of monitoring equipment in the ER.
Current applications include telehealth for COPD rehabilitation and falls prevention serving an area with a 60 mile radius and a province-wide telehealth/telecare service supporting the healthcare needs of urban, rural and remote native communities over a large area with varied climates and poor access. We were also shown a novel new facility to enable multi-disciplinary healthcare technology innovation and exploitation serving university and health service researchers”.
The medtechNorth conference was the first of what is intended to become an annual Canadian MedTech event. The programme included presentations, panels and discussions on topics of general interest including IP protection, the role of innovation, trends and issues, and the specific areas of rehabilitation, cardiovascular, imaging, ICT in healthcare, and diagnostics.
Sixteen companies at proof of concept or start-up stage pitched their offerings.
Attendees included health professionals, academics, investors and technologists.
Finally the six UK representatives joined a workshop with Canadian MedTech researchers to explore the scope for collaboration with UK healthcare researchers. A proposal is being developed and it is intended that a Canadian delegation will visits UK in September. Cambridge Wireless and One Nucleus members will have the opportunity to host visits and share knowledge and look for collaboration opportunities.
More information may be obtained from David Cudby of Networks for Independent Living, via Cambridge Wireless or Tony Jones, Director of Business Development at One Nucleus.
To find out more about upcoming events and to register your attendance please visit: http://www.cambridgewireless.co.uk/events/
- ENDS -
Notes for editors follow
For Cambridge Wireless please contact:
Martin Copland, Events and Marketing Executive, Cambridge Wireless
About Cambridge Wireless
Cambridge Wireless is a leading industry forum and vibrant community with a rapidly expanding network of companies actively involved in the development and application of wireless technologies. In addition to high level networking dinners, educational events and business development activities, Cambridge Wireless runs an annual Future of Wireless International Conference along with the Discovering Start-Ups initiative to support emerging, innovative wireless companies. Over 15 Special Interest Groups focused on specific technologies and market sectors, also provide opportunities for members to meet, form partnerships to exploit new commercial opportunities, and share knowledge and information about the latest industry trends and hot topics. Cambridge Wireless has partnerships with other leading industry clusters and organisations around the world to extend its international reach and to keep members up to date with the latest global developments and business opportunities. For more information, please visit www.cambridgewireless.co.uk
About One Nucleus
One Nucleus is a membership organisation for international life science and healthcare companies. One Nucleus is a not-for-profit, membership organisation and located in Cambridge and London – the centre of Europe’s leading life science and healthcare cluster. They have more than 500 members include pharmaceutical, biotech, medical device and diagnostic companies and associated technical and commercial service providers. One Nucleus was formed in April 2010 by the merger of two regional lifescience networks – Cambridge-based ERBI and the London Biotechnology Network (LBN). Together they form a commercial, clinical and academic powerhouse. London and Cambridge are home to at least 60% of the UK’s life science industry base, four of the UK’s five Academic Health Science Centres and three of the world’s top six universities. The merger of ERBI and LBN recognises that the Cambridge-London network is an international life science “super cluster”.